Pharmacies only have until Monday to express interest in participating in the Chronic Pain MedsCheck Trial
The Guild has issued a reminder to its members to register by Midnight AEST Monday 17 September if they wish to take part.
The long-awaited trial was placed on hold in March due to the need to meet Commonwealth Grants Rules and Guidelines, but is now moving ahead quickly.
“Pharmacies that have a consulting area are urged to think about taking part in this trial which in the long-term has the potential to make a real difference to the health outcomes of chronic pain sufferers,” says the Guild.
The trial is being funded by the Health Department as part of the Pharmacy Trial Program under the 6CPA.
“The 6CPA PTP was established to trial new and expanded community pharmacy programs that seek to improve clinical outcomes for consumers by progressing the role of community pharmacies in the delivery of primary healthcare services,” says the Guild.
The Chronic Pain MedsCheck Trial aims to assess the efficacy of the Chronic Pain MedsCheck service, in the areas of preventing incorrect use and/or overuse of pain medication; increasing patients’ pain medication health literacy; improving their ability to self-manage chronic pain; and improving overall quality of life.
It was announced in January 2018 by Health Minister Greg Hunt, who said that all community pharmacies would be able to participate.
“Community pharmacies participating in the trial will build relationships with GPs and other health professionals who support patients with chronic pain,” the Minister said at the time.